Compound Information | SONAR Target prediction | Name: | 5alpha-ANDROSTAN-3beta,17beta-DIOL | Unique Identifier: | SPE00107100 | MolClass: | Checkout models in ver1.5 and ver1.0 | Molecular Formula: | C19H32O2 | Molecular Weight: | 261.21 g/mol | X log p: | -0.0960000000000001 (online calculus) | Lipinksi Failures | 0 | TPSA | 0 | Hydrogen Bond Donor Count: | 0 | Hydrogen Bond Acceptors Count: | 2 | Rotatable Bond Count: | 0 | Canonical Smiles: | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O | Source: | testosterone metabolite | Reference: | J Org Chem 26: 2043 (1961); J Med Chem 9: 924 (1966) | Generic_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Chemical_iupac_name: | 5-ALPHA-ANDROSTANE-3-BETA,17BETA-DIOL | Drug_type: | Experimental | Drugbank_id: | EXPT00530 | Logp: | 3.73 | Drug_category: | Sex Hormone-Binding Globulin inhibitor | Organisms_affected: | -1 |
Species: |
4932 |
Condition: |
YPT6 |
Replicates: |
2 |
Raw OD Value: r im |
0.2102±0.0262337 |
Normalized OD Score: sc h |
0.5072±0.037657 |
Z-Score: |
-5.0057±0.315444 |
p-Value: |
0.000000950292 |
Z-Factor: |
0.39913 |
Fitness Defect: |
13.8665 |
Bioactivity Statement: |
Active |
Experimental Conditions | | Library: | Spectrum | Plate Number and Position: | 22|H7 | Drug Concentration: | 50.00 nM | OD Absorbance: | 600 nm | Robot Temperature: | 27.30 Celcius | Date: | 2006-02-22 YYYY-MM-DD | Plate CH Control (+): | 0.0413±0.00084 | Plate DMSO Control (-): | 0.377575±0.02225 | Plate Z-Factor: | 0.7296 |
| png ps pdf |
7829989 |
(5R,8S,9S,10S,13R,14R,16R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta [a]phenanthren-16-ol |
10975445 |
(1R,4S,6S)-bicyclo[2.2.1]heptan-6-ol |
10975454 |
(1S)-2-methylcyclohexan-1-ol |
11075068 |
2-[(1R,4R,4aS,7S,8aS)-4,7-dimethyl-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-1-yl]propan-2-ol |
11076083 |
(2S,3S)-3,7-dimethylpentadecan-2-ol |
11475087 |
n/a |
internal high similarity DBLink | Rows returned: 38 | 1 2 3 4 5 6 7 Next >> |
active | Cluster 12674 | Additional Members: 6 | Rows returned: 4 | |
|